World's first vaccine for hepatitis E launched
Source: Xinhua |
October 28, 2012, Sunday
|
Print Edition
Print Edition
THE world's first hepatitis E vaccine "Hecolin" is now available on the Chinese market, a pharmaceutical company confirmed yesterday.
The vaccine hit the market after a two-year clinical trial involving 113,000 volunteers in eastern Jiangsu Province.
Developed by Xiamen University and Xiamen Innovax Biotech Co Ltd in southeast China's Fujian Province, the vaccine was approved for production late last year.
At a launch in the city of Xiamen, Gao Yongzhong, general manager of Xiamen Innovax, said the company is working with the government to offer the vaccine to high-risk members of the public and cooperating with international organizations for use abroad.
The hepatitis E virus is shed in feces and spread through water and food. In China, it is the most common type of hepatitis infecting adults.
The vaccine hit the market after a two-year clinical trial involving 113,000 volunteers in eastern Jiangsu Province.
Developed by Xiamen University and Xiamen Innovax Biotech Co Ltd in southeast China's Fujian Province, the vaccine was approved for production late last year.
At a launch in the city of Xiamen, Gao Yongzhong, general manager of Xiamen Innovax, said the company is working with the government to offer the vaccine to high-risk members of the public and cooperating with international organizations for use abroad.
The hepatitis E virus is shed in feces and spread through water and food. In China, it is the most common type of hepatitis infecting adults.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
